MedTrace Logo

Pivotal Study of the Cutera truSculpt Radiofrequency Device for Wrinkle Reduction

NCT03285581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2023-09-13

Study results available
· View outcomes & findings →

Summary

The purpose of this pivotal investigation is to evaluate the safety and efficacy of the Cutera truSculpt™ radiofrequency (RF) Device for Wrinkle Reduction.

Conditions

  • Wrinkle Reduction

Interventions

DEVICE

truSculpt RF

Subjects will receive RF treatments

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, M.D. · Cutera Research Center

  • Daniel Friedmann, M.D. · Westlake Dermatology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2018-12-20
Completion
2018-12-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03285581 on ClinicalTrials.gov